What are the laboratory reference ranges for estradiol, follicle‑stimulating hormone (FSH), and luteinizing hormone (LH) in a post‑menopausal woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Reference Ranges for Estradiol, FSH, and LH in Menopause

In postmenopausal women, expect FSH >25 IU/L (typically averaging 37 IU/L with a range of 26-64 IU/L), estradiol <20 pg/mL, and elevated LH levels, though specific LH thresholds are less well-defined than FSH.

FSH (Follicle-Stimulating Hormone)

The diagnostic threshold for ovarian insufficiency is FSH >25 IU/L on two separate assays performed at least 4 weeks apart 1. This represents the internationally consensual reference value for diagnosing premature ovarian insufficiency and applies to physiologic menopause as well.

Key Points About FSH:

  • The average FSH level in ovarian insufficiency is 37 IU/L (range 26-64 IU/L) 1
  • FSH elevation >25 IU/L in a woman (outside the pre-ovulation peak) indicates ovarian insufficiency 1
  • Repeat testing is essential: A second confirmatory FSH measurement should be obtained at least 4 weeks after the initial elevated value 1
  • FSH levels can be falsely suppressed in women taking combined estrogen-progestin contraception or macro-progestins with antigonadotropic action; discontinue these medications for at least 3 months before retesting 1

Estradiol

Estradiol levels are low in menopause, typically <20 pg/mL 2. The guideline evidence specifically states that estradiol concentrations <20 pg/mL on several occasions support the diagnosis of menopause 2.

Important Caveats:

  • Low estradiol confirms the diagnosis and rules out the possibility that FSH was measured during a pre-ovulation peak 1
  • During pre-ovulation peaks, estradiol is typically 150-200 pg/mL per mature follicle 1
  • Current direct estradiol assays are insensitive below 20 pg/mL, making precise measurement at very low levels challenging 3

LH (Luteinizing Hormone)

While the provided guidelines emphasize FSH and estradiol for diagnosing menopause, LH is also elevated in the postmenopausal state, though specific reference ranges are not as clearly defined in the evidence provided 4. LH should be measured as part of the initial hormonal assessment but is not the primary diagnostic criterion.

Clinical Algorithm for Diagnosis:

  1. First measurement: Obtain FSH and estradiol (ideally during days 1-7 of menstrual cycle if cycles still present)
  2. If FSH >25 IU/L and estradiol <20 pg/mL: Repeat both measurements at least 4 weeks later
  3. Confirm diagnosis: Two FSH values >25 IU/L at least 4 weeks apart, with low estradiol
  4. Important: Ensure patient is not on hormonal contraception or antigonadotropic medications that could suppress FSH

Common Pitfalls to Avoid:

  • Do not rely on a single FSH measurement - fluctuations can occur, particularly in perimenopause 1
  • Check medication history - hormonal contraceptives will artificially lower FSH and must be discontinued for at least 3 months before accurate assessment 1
  • Timing matters - avoid testing during mid-cycle when physiologic FSH/LH surges occur 1
  • Laboratory quality - use a reliable laboratory with accurate reference ranges, as commercial labs often have inconsistent normal ranges 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.